Selected Publications: 20-25 publications listed in details with all the contributing authors, title of the papers, journal, dates.

 

1) Della Porta MG, Jackson CH, Alessandrino EP, Rossi M, Bacigalupo A, van Lint

MT, Bernardi M, Allione B, Bosi A, Guidi S, Santini V, Malcovati L, Ubezio M,

Milanesi C, Todisco E, Voso MT, Musto P, Onida F, Iori AP, Cerretti R, Grillo G,

Molteni A, Pioltelli P, Borin L, Angelucci E, Oldani E, Sica S, Pascutto C,

Ferretti V, Santoro A, Bonifazi F, Cazzola M, Rambaldi A. Decision analysis of

allogeneic hematopoietic stem cell transplantation for patients with

myelodysplastic syndrome stratified according to the revised International

Prognostic Scoring System. Leukemia. 2017 Nov;31(11):2449-2457. doi:

10.1038/leu.2017.88. Epub 2017 Mar 21. PubMed PMID: 28321120; PubMed Central PMCID: PMC6086331.

 

2: Della Porta MG, Gallì A, Bacigalupo A, Zibellini S, Bernardi M, Rizzo E,

Allione B, van Lint MT, Pioltelli P, Marenco P, Bosi A, Voso MT, Sica S, Cuzzola

M, Angelucci E, Rossi M, Ubezio M, Malovini A, Limongelli I, Ferretti VV,

Spinelli O, Tresoldi C, Pozzi S, Luchetti S, Pezzetti L, Catricalà S, Milanesi C,

Riva A, Bruno B, Ciceri F, Bonifazi F, Bellazzi R, Papaemmanuil E, Santoro A,

Alessandrino EP, Rambaldi A, Cazzola M. Clinical Effects of Driver Somatic

Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2016 Oct 20;34(30):3627-3637. doi: 10.1200/JCO.2016.67.3616. PubMed PMID: 27601546.

 

3: Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jädersten M, Jansson M,

Elena C, Gallì A, Walldin G, Della Porta MG, Raaschou-Jensen K, Travaglino E,

Kallenbach K, Pietra D, Ljungström V, Conte S, Boveri E, Invernizzi R, Rosenquist

R, Campbell PJ, Cazzola M, Hellström Lindberg E. SF3B1 mutation identifies a

distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood. 2015

Jul 9;126(2):233-41. doi: 10.1182/blood-2015-03-633537. Epub 2015 May 8. PubMed PMID: 25957392; PubMed Central PMCID: PMC4528082.

 

4: Della Porta MG, Tuechler H, Malcovati L, Schanz J, Sanz G, Garcia-Manero G,

Solé F, Bennett JM, Bowen D, Fenaux P, Dreyfus F, Kantarjian H, Kuendgen A, Levis A, Cermak J, Fonatsch C, Le Beau MM, Slovak ML, Krieger O, Luebbert M,

Maciejewski J, Magalhaes SM, Miyazaki Y, Pfeilstöcker M, Sekeres MA, Sperr WR, Stauder R, Tauro S, Valent P, Vallespi T, van de Loosdrecht AA, Germing U, Haase D, Greenberg PL, Cazzola M. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM). Leukemia. 2015 Jul;29(7):1502-13. doi: 10.1038/leu.2015.55. Epub 2015 Feb 27. PubMed PMID: 25721895.

 

5: Malcovati L, Papaemmanuil E, Ambaglio I, Elena C, Gallì A, Della Porta MG,

Travaglino E, Pietra D, Pascutto C, Ubezio M, Bono E, Da Vià MC, Brisci A, Bruno

F, Cremonesi L, Ferrari M, Boveri E, Invernizzi R, Campbell PJ, Cazzola M. Driver

somatic mutations identify distinct disease entities within myeloid neoplasms

with myelodysplasia. Blood. 2014 Aug 28;124(9):1513-21. doi:

10.1182/blood-2014-03-560227. Epub 2014 Jun 26. PubMed PMID: 24970933; PubMed Central PMCID: PMC4148773.

 

6: Della Porta MG, Travaglino E, Boveri E, Ponzoni M, Malcovati L, Papaemmanuil E, Rigolin GM, Pascutto C, Croci G, Gianelli U, Milani R, Ambaglio I, Elena C, Ubezio M, Da Via’ MC, Bono E, Pietra D, Quaglia F, Bastia R, Ferretti V, Cuneo A, Morra E, Campbell PJ, Orazi A, Invernizzi R, Cazzola M. Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes. Leukemia. 2015 Jan;29(1):66-75. doi: 10.1038/leu.2014.161. Epub 2014 May 20. PubMed PMID: 24935723.

 

7: Porwit A, van de Loosdrecht AA, Bettelheim P, Brodersen LE, Burbury K, Cremers E, Della Porta MG, Ireland R, Johansson U, Matarraz S, Ogata K, Orfao A, Preijers F, Psarra K, Subirá D, Valent P, van der Velden VH, Wells D, Westers TM, Kern W, Béné MC. Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS. Leukemia. 2014 Sep;28(9):1793-8. doi: 10.1038/leu.2014.191. Epub 2014 Jun 12. PubMed PMID: 24919805.

 

8: Della Porta MG, Alessandrino EP, Bacigalupo A, van Lint MT, Malcovati L,

Pascutto C, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco

P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Bernasconi P, Bosi A, Cazzola

M, Rambaldi A; Gruppo Italiano Trapianto di Midollo Osseo. Predictive factors for

the outcome of allogeneic transplantation in patients with MDS stratified

according to the revised IPSS-R. Blood. 2014 Apr 10;123(15):2333-42. doi:

10.1182/blood-2013-12-542720. Epub 2014 Feb 20. PubMed PMID: 24558201.

 

9: Cazzola M, Della Porta MG, Malcovati L. The genetic basis of myelodysplasia

and its clinical relevance. Blood. 2013 Dec 12;122(25):4021-34. doi:

10.1182/blood-2013-09-381665. Epub 2013 Oct 17. Review. PubMed PMID: 24136165; PubMed Central PMCID: PMC3862275.

 

10: Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P, Yoon CJ, Ellis P, Wedge DC, Pellagatti A, Shlien A, Groves MJ, Forbes SA, Raine K, Hinton J, Mudie LJ, McLaren S, Hardy C, Latimer C, Della Porta MG, O’Meara S, Ambaglio I, Galli A, Butler AP, Walldin G, Teague JW, Quek L, Sternberg A,

Gambacorti-Passerini C, Cross NC, Green AR, Boultwood J, Vyas P, Hellstrom-Lindberg E, Bowen D, Cazzola M, Stratton MR, Campbell PJ; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium.

Clinical and biological implications of driver mutations in myelodysplastic

syndromes. Blood. 2013 Nov 21;122(22):3616-27; quiz 3699. doi: 10.1182/blood-2013-08-518886. Epub 2013 Sep 12. PubMed PMID: 24030381; PubMed

Central PMCID: PMC3837510.

 

11: Pellagatti A, Benner A, Mills KI, Cazzola M, Giagounidis A, Perry J,

Malcovati L, Della Porta MG, Jädersten M, Verma A, McDonald EJ, Killick S,

Hellström-Lindberg E, Bullinger L, Wainscoat JS, Boultwood J. Identification of

gene expression-based prognostic markers in the hematopoietic stem cells of

patients with myelodysplastic syndromes. J Clin Oncol. 2013 Oct 1;31(28):3557-64. doi: 10.1200/JCO.2012.45.5626. Epub 2013 Sep 3. PubMed PMID: 24002510.

 

12: Malcovati L, Hellström-Lindberg E, Bowen D, Adès L, Cermak J, Del Cañizo C,

Della Porta MG, Fenaux P, Gattermann N, Germing U, Jansen JH, Mittelman M, Mufti G, Platzbecker U, Sanz GF, Selleslag D, Skov-Holm M, Stauder R, Symeonidis A, van de Loosdrecht AA, de Witte T, Cazzola M; European Leukemia Net. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood. 2013 Oct 24;122(17):2943-64. doi: 10.1182/blood-2013-03-492884. Epub 2013 Aug 26. PubMed PMID: 23980065; PubMed Central PMCID: PMC3811170.

 

13: Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, Burbury

K, Cullen M, Cutler JA, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing

U, Haase D, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG,

Matarraz S, Milne T, Moshaver B, Mufti GJ, Ogata K, Orfao A, Porwit A, Psarra K,

Richards SJ, Subirá D, Tindell V, Vallespi T, Valent P, van der Velden VH, de

Witte TM, Wells DA, Zettl F, Béné MC, van de Loosdrecht AA. Standardization of

flow cytometry in myelodysplastic syndromes: a report from an international

consortium and the European LeukemiaNet Working Group. Leukemia. 2012

Jul;26(7):1730-41. doi: 10.1038/leu.2012.30. Epub 2012 Feb 6. PubMed PMID:

22307178.

 

14: Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D,

Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, Godfrey AL, Rapado I, Cvejic A, Rance R, McGee C, Ellis P, Mudie LJ, Stephens PJ, McLaren S, Massie CE, Tarpey PS, Varela I, Nik-Zainal S, Davies HR, Shlien A, Jones D, Raine K, Hinton J, Butler AP, Teague JW, Baxter EJ, Score J, Galli A, Della Porta MG, Travaglino E, Groves M, Tauro S, Munshi NC, Anderson KC, El-Naggar A, Fischer A, Mustonen V, Warren AJ, Cross NC, Green AR, Futreal PA, Stratton MR, Campbell PJ; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011 Oct 13;365(15):1384-95. doi: 10.1056/NEJMoa1103283. Epub 2011 Sep 26. PubMed PMID: 21995386; PubMed Central PMCID: PMC3322589.

 

15: Malcovati L, Della Porta MG, Pietra D, Boveri E, Pellagatti A, Gallì A,

Travaglino E, Brisci A, Rumi E, Passamonti F, Invernizzi R, Cremonesi L,

Boultwood J, Wainscoat JS, Hellström-Lindberg E, Cazzola M. Molecular and

clinical features of refractory anemia with ringed sideroblasts associated with

marked thrombocytosis. Blood. 2009 Oct 22;114(17):3538-45. doi: 10.1182/blood-2009-05-222331. Epub 2009 Aug 19. PubMed PMID: 19692701.

 

16: Della Porta MG, Malcovati L, Boveri E, Travaglino E, Pietra D, Pascutto C,

Passamonti F, Invernizzi R, Castello A, Magrini U, Lazzarino M, Cazzola M.

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in

primary myelodysplastic syndromes. J Clin Oncol. 2009 Feb 10;27(5):754-62. doi:

10.1200/JCO.2008.18.2246. Epub 2008 Dec 22. PubMed PMID: 19103730.

 

17: Alessandrino EP, Della Porta MG, Bacigalupo A, Van Lint MT, Falda M, Onida F, Bernardi M, Iori AP, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Malcovati L,

Pascutto C, Oneto R, Fanin R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo

(GITMO). WHO classification and WPSS predict posttransplantation outcome in

patients with myelodysplastic syndrome: a study from the Gruppo Italiano

Trapianto di Midollo Osseo (GITMO). Blood. 2008 Aug 1;112(3):895-902. doi:

10.1182/blood-2008-03-143735. Epub 2008 May 22. PubMed PMID: 18497321.

 

18: Della Porta MG, Malcovati L, Rigolin GM, Rosti V, Bonetti E, Travaglino E,

Boveri E, Gallì A, Boggi S, Ciccone M, Pramparo T, Mazzini G, Invernizzi R,

Lazzarino M, Cazzola M. Immunophenotypic, cytogenetic and functional

characterization of circulating endothelial cells in myelodysplastic syndromes.

Leukemia. 2008 Mar;22(3):530-7. Epub 2007 Dec 20. PubMed PMID: 18094717.

 

19: Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007 Aug 10;25(23):3503-10. PubMed PMID: 17687155.

 

20: Della Porta MG, Malcovati L, Invernizzi R, Travaglino E, Pascutto C, Maffioli

M, Gallì A, Boggi S, Pietra D, Vanelli L, Marseglia C, Levi S, Arosio P,

Lazzarino M, Cazzola M. Flow cytometry evaluation of erythroid dysplasia in

patients with myelodysplastic syndrome. Leukemia. 2006 Apr;20(4):549-55. PubMed PMID: 16498394.